Press & Announcements
New York City-based Investment Bank boutique HealthPro BioVentures announced today the appointment of James Kuo, M.D., M.B.A., as managing director of its newly opened San Diego, CA office. Dr. Kuo’s joining HealthPro expands the organization’s capabilities to include strategic management support, in addition to HealthPro’s ongoing services of capital financings, mergers and acquisitions, and licensing and partnering.
Transgene Biotek Ltd, one of India’s earliest biotechnology companies, signalled its continued westward expansion with the signing of a Memorandum-of-Understanding with Armour Therapeutics Inc. of Toronto, Canada. Transgene and Armour are exploring a strategic relationship to co-develop Armour’s drug candidates for reproductive cancers. Armour’s lead anti-relaxin molecule, AT-001, is being developed to treat hormone refractory prostate cancer.
OncoVista Innovative Therapies, Inc. (OTCBB:OVIT.ob - News), a high-growth global biopharmaceutical company commercializing diagnostic tests for metastatic tumors, as well as developing targeted, personal anticancer therapies by utilizing tumor-associated biomarkers, recently announced that the Company had divested its majority holding of subsidiary AdnaGen AG.
HealthPro BioVentures, LLC of New York is pleased to announce that HealthPro has acted as advisor to ProMetic Life Sciences. Abraxis and ProMetic have recently entered into license agreements for up to US $295 million for four biopharmaceuticals. In addition, Abraxis has made an initial US $7 million equity investment in ProMetic, with future additional optional equity investments of up to US $25 million.
SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced the engagement of HealthPro BioVentures LLC (”HealthPro”), a life sciences investment bank and strategic advisory firm, as its financial advisor in connection with the evaluation of various prospective transactions, and identifying and evaluating potential strategic partners.
MedeFile International, Inc. (OTCQB: MDFI) (PINKSHEETS: MDFI), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, today announced that it has engaged HealthPro BioVentures, LLC with the sole objective of pursuing and structuring strategic co-marketing partnerships and healthcare IT collaborations with companies operating within the global healthcare arena.
HealthPro BioVentures, LLC and Corinthian Partners, LLC are pleased to announce a strategic collaboration in which both companies will share their respective resources and capabilities. HealthPro BioVentures is a boutique investment bank that focuses solely in the Healthcare and Life Sciences sector. Corinthian Partners is an investment bank/ asset management group with a specialty in renewable energy and resources.